Mitolyn Hits the Market with Best Supplement for Weight Loss Support (2025)
January 09, 2025 09:00 ET
|
Mitolyn
NEW YORK, NY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Unleashing Cellular Energy: How Mitolyn Supports Mitochondrial Health for Enhanced Vitality and Longevity Introducing Mitolyn, the innovative natural...
Mitolyn Unveils New “Purple Peel Exploit” to Support Metabolism and Mitochondrial Health
December 12, 2024 09:00 ET
|
Mitolyn
COLUMBUS, Ohio, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mitolyn, an innovative new dietary supplement, is setting the stage for a transformative approach to health with its launch. Engineered to elevate...
IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.
August 08, 2024 08:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...
Mblue Labs unveils the Anti-aging Powers of Methylene Blue, launches Bluelene HandPlus+ Advanced Age-Repair Treatment
June 25, 2024 08:00 ET
|
Mblue Labs
Mblue Labs announces the launch of Bluelene HandPlus+, an Advanced Anti-aging Treatment with Methylene Blue - the patented age-reversal ingredient
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Rob Etherington, CEO of Clene Inc.
October 10, 2023 08:17 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...
Ischemix, Inc. Receives US Department of Defense Funding of $2.9 million to Conduct Phase 1 Study of Drug Candidate to Treat Traumatic Brain Injury (TBI)
July 07, 2021 12:51 ET
|
Ischemix, Inc.
GRAFTON, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Ischemix, Inc., a private company focused on developing therapeutics for serious medical conditions, today announced that the US Department of...